-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
CME Group's Income Statement
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$4.69 B | $5.02 B | $5.58 B | $6.13 B | $6.52 B |
| Cost of Revenue |
|
$837.00 M | $753.10 M | $828.60 M | $850.30 M | $907.00 M |
| Gross Profit |
|
$3.85 B | $4.27 B | $4.75 B | $5.28 B | $5.61 B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
$151.70 M | $137.40 M | $144.40 M | $132.70 M | $150.50 M |
| Operating Expense |
|
$1.21 B | $1.25 B | $1.31 B | $1.35 B | $1.38 B |
| Operating Income |
|
$2.65 B | $3.02 B | $3.44 B | $3.93 B | $4.23 B |
| Net Income |
|
$2.64 B | $2.69 B | $3.23 B | $3.53 B | $4.04 B |
CME Group's Assets vs Liabilities & Equity
CME Group's Balance Sheet
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$2.95 B | $2.82 B | $3.02 B | $3.01 B | $4.55 B |
| Inventories |
|
- | - | - | - | - |
| Total Current Assets |
|
$161.76 B | $139.08 B | $94.89 B | $103.03 B | - |
| Property,Plant and Equipment |
|
$505.30 M | $455.50 M | $409.50 M | $386.20 M | $362.70 M |
| Goodwill |
|
$10.53 B | $10.48 B | $10.50 B | $10.49 B | $10.51 B |
| Total Assets |
|
$196.78 B | $174.18 B | $129.71 B | $137.45 B | $198.42 B |
| Total Liabilities |
|
$169.38 B | $147.30 B | $102.97 B | $110.96 B | $169.70 B |
| Retained Earnings |
|
$5.15 B | $4.75 B | $4.46 B | $4.19 B | - |
| Total Shareholder Equity |
|
$27.40 B | $26.88 B | $26.74 B | $26.49 B | $28.73 B |
| Common Stock |
|
$3.60 M | $3.60 M | $3.60 M | $3.60 M | - |
CME Group's Cash flow
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$385.40 M | $362.60 M | $352.60 M | $336.80 M | $223.40 M |
| Dividends Payout |
|
-$2.19 B | -$2.63 B | -$3.24 B | -$3.58 B | - |
| Capital Expenditures (Capex) |
|
-$127.20 M | -$89.70 M | -$76.40 M | -$94.00 M | - |
| Free Cash Flow (FCF) |
|
$2.28 B | $2.97 B | $3.38 B | $3.60 B | $4.28 B |
CME Group's Profitability
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$3.85 B | $4.27 B | $4.75 B | $5.28 B | $5.61 B |
| Gross Profit Margin (%) |
|
82.15% | 85.00% | 85.15% | 86.13% | 86.09% |
| Operating Income |
|
$2.65 B | $3.02 B | $3.44 B | $3.93 B | $4.23 B |
| Operating Income Margin (%) |
|
56.40% | 60.08% | 61.58% | 64.13% | 64.86% |
| Net Income |
|
$2.64 B | $2.69 B | $3.23 B | $3.53 B | $4.04 B |
| Net Income Margin (%) |
|
56.22% | 53.61% | 57.83% | 57.52% | 62.02% |
| EBITDA |
|
$3.93 B | $4.02 B | $4.67 B | $5.04 B | $5.72 B |
| EBITDA Margin (%) |
|
83.71% | 80.00% | 83.63% | 82.20% | 87.73% |
CME Group's Ratios
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
9.69% | 10.06% | 12.07% | 13.31% | - |
| Return on Assets (ROA) |
|
1.34% | 1.54% | 2.49% | 2.57% | - |
| Debt to Equity |
|
12.57% | 12.79% | 12.81% | 12.94% | 13.08% |
| Debt to total asset |
|
1.75% | 1.97% | 2.64% | 2.49% | 1.89% |
| Enterprise value to revenue |
|
17.59 | 12.16 | 13.73 | 13.77 | 0.00 |
| Enterprise value to EBITDA |
|
21.01 | 15.20 | 16.41 | 16.75 | 0.00 |
| Enterprise value |
|
$82.48 B | $61.04 B | $76.58 B | $84.39 B | - |
| Tax Rate (%) |
|
21.84% | 22.90% | 22.33% | 22.36% | 23.89% |
Frequently Asked Questions
